MeiraGTx Holdings plc Public Float
MeiraGTx Holdings plc (MGTX) had Public Float of $524.51 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $524.51M.
- 2024-06-28: Entity Public Float $272.32M.
- 2023-06-30: Entity Public Float $259.94M.
- 2022-06-30: Entity Public Float $242.66M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $524.51M 10-K · filed 2026-03-30 |
| 2024-06-28 | $272.32M 10-K · filed 2025-03-13 |
| 2023-06-30 | $259.94M 10-K · filed 2024-03-15 |
| 2022-06-30 | $242.66M 10-K · filed 2023-03-14 |
| 2021-06-30 | $458.61M 10-K · filed 2022-03-10 |
| 2020-06-30 | $284.75M 10-K · filed 2021-03-11 |
| 2019-06-28 | $511.32T 10-K · filed 2020-03-11 |
| 2018-06-30 | $154.60M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |